Molecular-genetic aspects of the diagnosis of myeloproliferative diseases demonstrated on the example of polycythemia vera.

Molecular genetic testing is a reliable method for the definitive diagnosis of polycythemia vera (PV). The use of interferon preparations in addition to hydroxyurea and antiplatelet agents could be associated with better therapeutic outcomes. In this report, we present the clinical case of a young patient with asymptomatic PV to demonstrate the effectiveness of molecular genetic analysis in PV diagnosis.